The first Mustang Bio trade was made in Q3 2018.
Since then Ken Griffin bought shares nine more times and sold shares on eight occasions. The investor sold all their shares in Q2 2023 and doesn't own any shares in Mustang Bio anymore.
Avg closing price
Price range
Sold -3.86 Thousand shares
Q2 2023
Avg closing price
$6.12
Price range
$2.82
-
$73.15
New holding (+3.86 Thousand shares)
Q1 2023
Avg closing price
$122.97
Price range
$78.66
-
$162.00
Sold -36.9 Thousand shares
Q3 2022
Avg closing price
$138.99
Price range
$95.60
-
$171.43
Increased shares by 1347.3% (+34.3 Thousand shares)
Q2 2022
Avg closing price
$166.09
Price range
$129.71
-
$254.25
Sold 73.1% shares (-6.91 Thousand shares)
Q1 2022
Avg closing price
$246.47
Price range
$164.32
-
$407.25
Increased shares by 59.1% (+3.52 Thousand shares)
Q4 2021
Avg closing price
$484.38
Price range
$373.50
-
$594.00
Sold 56.0% shares (-7.57 Thousand shares)
Q3 2021
Avg closing price
$644.45
Price range
$580.50
-
$756.00
Increased shares by 166.0% (+8.43 Thousand shares)
Q2 2021
Avg closing price
$735.36
Price range
$607.50
-
$857.25
Sold 64.6% shares (-9.29 Thousand shares)
Q1 2021
Avg closing price
$891.83
Price range
$679.50
-
$1,161.00
Increased shares by 510.1% (+12 Thousand shares)
Q3 2020